Patent · US Active

Implantable cellular and biotherapeutic agent delivery canister

US11857670B2 · kind B2 · utility

0Cited by
11References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2020
Grant dateJan 2, 2024
Priority date
Expiry dateDec 22, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.